meetup #12
Learn about challenges, innovations, and best practices related to access control in FHIR-enabled systems.
WATCH NOWIn the era of digital health, ensuring secure and compliant access to healthcare data is paramount. FHIR has emerged as a standard for healthcare data exchange, offering a framework for managing data access across systems. Implementing FHIR access control poses unique challenges and opportunities for healthcare organizations, developers, and stakeholders.
What to Expect?
Our meetup brings experts to the forefront of addressing FHIR access control challenges. Through a series of talks, discussions, and Q&A sessions, we will explore:
1. Ongoing Challenges: Dive into the current landscape of healthcare data governance, focusing on patient consent management, data sharing, and regulatory compliance challenges.
2. Use Cases: Learn from real-world use cases demonstrating the benefits of effective Consent-based and Label-based access control. From enhancing patient data security to facilitating seamless data sharing between organizations, discover how FHIR access control is transforming healthcare.
3. Best Practices and Solutions: Learn the best practices for implementing FHIR access control, including granular access policies, scalability considerations, and compliance with FHIR specifications.
This meetup is ideal for healthcare IT professionals, developers, data architects, compliance officers, and anyone interested in the intersection of healthcare data privacy, security, and interoperability.
To get the slides join the HealthDevHub Slack channel.
Please fill out the registration form to join the meetup. We will send you a reminder with the Zoom link one day before the event.
Any questions? Feel free to reach out at: info@healthdevhub.com
Join our subscribers list to get educational materials, updates and interesting articles about Aidbox & HL7 FHIR.
FHIR® is the registered trademark of HL7 and is used with the permission of HL7. This event is not sponsored by HL7. The FHIR trademark does not constitute endorsement of the content of the products and/or presentations presented by HL7.